Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Samenvatting

Summary current medical diagnosis and treatment 2023

Beoordeling
-
Verkocht
-
Pagina's
849
Geüpload op
14-06-2023
Geschreven in
2022/2023

Disease Prevention & Health Promotion suppression. However, studies show that 40% of patients are less than 90% adherent and that adherence tends to decrease over time. Patient reasons for suboptimal adherence include sim- ple forgetfulness, being away from home, being busy, and changing daily routine. Other reasons include psychiatric disorders (depression or substance misuse), uncertainty about the effectiveness of treatment, lack of knowledge about the consequences of poor adherence, regimen com- plexity, and treatment side effects. he rising costs of medi- cations, including generic drugs, and the increase in patient cost-sharing burden, have made adherence even more difficult, particularly for those with lower incomes. Patients seem better able to take prescribed medications than to adhere to recommendations to change their diet, exercise habits, or alcohol intake or to perform various self- care activities (such as monitoring blood glucose levels at home). For short-term regimens, adherence to medications can be improved by giving clear instructions. Writing out advice to patients, including changes in medication, may be helpful. Because low functional health literacy is com- mon (almost half of English-speaking US patients are unable to read and understand standard health education materials), other forms of communication—such as illus- trated simple text, videotapes, or oral instructions—may be more effective. For non–English-speaking patients, clini- cians and health care delivery systems can work to provide culturally and linguistically appropriate health services. o help improve adherence to long-term regimens, cli- nicians can work with patients to reach agreement on the goals for therapy, provide information about the regimen, ensure understanding by using the “teach-back” method, counsel about the importance of adherence and how to organize medication-taking, reinforce self-monitoring, provide more convenient care, prescribe a simple dosage regimen for all medications (preferably one or two doses daily), suggest ways to help in remembering to take doses (time of day, mealtime, alarms) and to keep appoint- ments, prescribe lower-cost generic medications when available, and provide ways to simplify dosing (medica- tion boxes). Single-unit doses supplied in foil wrappers can increase adherence but should be avoided for patients who have difficulty opening them. Medication boxes with 1Dr. Pignone is a former member of the US Preventive Services ask Force (USPSF). Te views expressed in this chapter are his and Dr. Salazar’s and not necessarily those of the USPSF. CHAPTER 12 CMDT 2023 compartments (eg, Medisets) that are filled weekly are use- ful. Microelectronic devices can provide feedback to show patients whether they have taken doses as scheduled or to notify patients within a day if doses are skipped. Remind- ers, including cell phone text messages, are another effec- tive means of encouraging adherence. he clinician can also enlist social support from family and friends, recruit an adherence monitor, provide a more convenient care environment, and provide rewards and recognition for the patient’s efforts to follow the regimen. Collaborative pro- grams in which pharmacists help ensure adherence are also effective. Motivational interviewing techniques can be helpful when patients are ambivalent about their therapy. Adherence is also improved when a trusting doctor- patient relationship has been established and when patients actively participate in their care. Clinicians can improve patient adherence by inquiring specifically about the behaviors in question. When asked, many patients admit to incomplete adherence with medication regimens, with advice about giving up cigarettes, or with engaging only in “safer sex” practices. Although difficult, sufficient time must be made available for communication of health messages. Medication adherence can be assessed generally with a single question: “In the past month, how often did you take your medications as the doctor prescribed?” Other ways of assessing medication adherence include pill counts and refill records; monitoring serum, urine, or saliva levels of drugs or metabolites; watching for appointment nonatten- dance and treatment nonresponse; and assessing predict- able drug effects, such as weight changes with diuretics or bradycardia from beta-blockers. In some conditions, even partial adherence, as with drug treatment of hypertension and diabetes mellitus, improves outcomes compared with nonadherence; in other cases, such as HIV antiretroviral therapy or tuberculosis treatment, partial adherence may be worse than complete nonadherence. » Guiding Principles of Care Ethical decisions are often called for in medical practice, at both the “micro” level of the individual patient-clinician relationship and at the “macro” level of allocation of resources or the adoption of infection-reducing public health interventions. Ethical principles that guide the suc- cessful approach to diagnosis and treatment are honesty, beneficence, justice, avoidance of conflict of interest, and the pledge to do no harm. Increasingly, Western medicine involves patients in important decisions about medical care, eg, which colorectal screening test to obtain or which modality of therapy for breast cancer or how far to proceed with treatment of patients who have terminal illnesses (see Chapter 5). he clinician’s role does not end with diagnosis and treatment. he importance of the empathic clinician in helping patients and their families bear the burden of seri- ous illness and death cannot be overemphasized. “o cure sometimes, to relieve often, and to comfort always” is a French saying as apt today as it was five centuries ago—as is Francis Peabody’s admonition: “he secret of the care of the patient is in caring for the patient.” raining to improve mindfulness and enhance patient-centered communica- tion increases patient satisfaction and may also improve clinician satisfaction. Daliri S et al. Medication-related interventions delivered both in hospital and following discharge: a systematic review and meta-analysis. BMJ Qual Saf. 2021;30:146. [PMID: ] Foley L et al. Prevalence and predictors of medication non- adherence among people living with multimorbidity: a system- atic review and meta-analysis. BMJ Open. 2021;11:e. [PMID: ] Peh KQE et al. An adaptable framework for factors contributing to medication adherence: results from a systematic review of 102 conceptual frameworks. J Gen Intern Med. 2021;36:2784. [PMID: ] º HEALTH MAINTENANCE & DISEASE PREVENTION Preventive medicine can be categorized as primary, sec- ondary, or tertiary. Primary prevention aims to remove or reduce disease risk factors (eg, immunization, giving up or not starting smoking). Secondary prevention techniques promote early detection of disease or precursor states (eg, routine cervical Papanicolaou screening to detect carci- noma or dysplasia of the cervix). ertiary prevention mea- sures are aimed at limiting the impact of established disease (eg, partial mastectomy and radiation therapy to remove and control localized breast cancer). ables 1–1 and 1–2 give leading causes of death in the United States for 2020 and recent estimates of deaths from preventable causes from 2019. he 2020 data demonstrate the large impact of COVID-19 on mortality and continue to show increased mortality rates, generally driven by the effects of COVID-19 as well as increases in deaths from Table 1–1. Leading causes of death in the United States, 2020. Category Estimate All causes 3,358,814 1. Diseases of the heart 690,882 2. Malignant neoplasms 598,932 3. COVID-19 345,323 4. Unintentional injuries 192,176 5. Cerebrovascular diseases 159,050 6. Chronic lower respiratory diseases 151,637 7. Alzheimer disease 133,382 8. Diabetes mellitus 101,106 9. Influenza and pneumonia 53,495 10. Nephritis, nephrotic syndrome, and nephrosis 52,260 11. Intentional self-harm (suicide) 44,834 Data from National Center for Health Statistics, 2021. DISEASE PREVENTION & HEALTH PROMOTION 3CMDT 2023 heart disease, unintentional injuries (including overdoses), and Alzheimer disease. Many effective preventive services are underutilized, and few adults receive all of the most strongly recom- mended services. Several methods, including the use of provider or patient reminder systems (including interac- tive patient health records), reorganization of care environ- ments, and possibly provision of financial incentives to clinicians (though this remains controversial), can increase utilization of preventive services, but such methods have not been widely adopted. Ahmad FB et al. he leading causes of death in the US for 2020. JAMA. 2021;325:1829. [PMID: ] Levine DM et al. Quality and experience of outpatient care in the United States for adults with or without primary care. JAMA Intern Med. 2019;179:363. [PMID: ] US Burden of Disease Collaborators. he state of US health, 1990–2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319:1444. [PMID: ] Woolf SH et al. Life expectancy and mortality rates in the United States, 1959–2017. JAMA. 2019;322:1996. [PMID: ] PREVENTION OF INFECTIOUS DISEASES Much of the historic decline in the incidence and fatality rates of infectious diseases is attributable to public health measures—especially immunization, improved sanitation, nonpharmacologic interventions (eg, mask-wearing to prevent respiratory-transmissible conditions), and better nutrition. his observation has been reinforced by the experience during the global COVID-19 pandemic. Immunization remains the best means of preventing many infectious diseases. Recommended immunization schedules for children and adolescents can be found online at , and the schedule for adults is at http:// Chapter 30 and Chapter 32). In addition to the severe toll in morbidity and mortality from COVID-19, substantial morbidity and mortality continues to occur from vaccine- preventable diseases, such as hepatitis A, hepatitis B, influ- enza, and pneumococcal infections. he high incidence and mortality rates from COVID-19 and other recent out- breaks of vaccine-preventable diseases in the United States highlight the need to understand the association of vaccine hesistancy or refusal and disease epidemiology and meth- ods for overcoming it. he Advisory Committee on Immunization Practices recommendations for the following vaccines appears in able 1–3: influenza; measles, mumps, and rubella; 23-valent pneumococcal polysaccharide vaccine; tetanus, diphtheria, and acellular pertussis; hepatitis B; and HPV. Persons traveling to countries where infections are endemic should take the precautions described in Chapter 30 and at Immunization registries—confidential, population-based, computerized information systems that collect vaccination data about all residents of a geographic area—can be used to increase and sustain high vaccination coverage. Globally, COVID-19 has resulted in over 5 million deaths. COVID-19 is caused by SARS-CoV-2. he impact on frontline workers, including health care workers, has been substantial, and the pandemic has revealed profound inequities in health and health care. In the United States, the COVID-19 mortality rates are higher in Black, Latinx, and Native American people compared to White people. hree COVID-19 vaccines are currently approved or authorized in the United States (Pfizer-BioNech/Comir- naty, Moderna, and Janssen [Johnson & Johnson]). Cur- rently, the CDC recommends everyone ages 5 and older get a COVID-19 vaccine to help protect against COVID-19 (see Chapter 32). Recent guidance has recommended third-dose boosters to be administered 6 months after pri- mary series completion for individuals receiving Pfizer and Moderna mRNA-vaccines and 2 months after those receiv- ing the Janssen adenovirus vector vaccine. he USPSF recommends behavioral counseling for adolescents and adults who are sexually active and at increased risk for sexually transmitted infections. Sexually active women aged 24 years or younger and older women who are at increased risk for infection should be screened for chlamydia and gonorrhea. Screening HIV-positive men or men who have sex with men for syphilis every 3 months is associated with improved syphilis detection. he CDC recommends universal HIV screening of all patients aged 13–64, and the USPSF recommends that clini- cians screen adolescents and adults aged 15–65 years. Clini- cians should integrate biomedical and behavioral approaches for HIV prevention. In addition to reducing sexual transmis- sion of HIV, initiation of antiretroviral therapy reduces the risk for AIDS-defining events and death among patients with less immunologically advanced disease. Daily preexposure prophylaxis (PrEP) with the fixed- dose combination of tenofovir disoproxil 300 mg and emtricitabine 200 mg (ruvada) should be considered for people who are HIV-negative but at substantial risk for HIV infection. Studies of men who have sex with men suggest that PrEP is very effective in reducing the risk of Table 1–2. Leading preventable causes of death in the United States, 2019. Category Estimate Tobacco 546,401 High blood pressure 495,201 High fasting plasma glucose 439,212 Dietary risks 418,350 High BMI 392,352 High LDL cholesterol 226,343 Impaired kidney function 214,740 Alcohol use 136,866 Non-optimal temperature 126,623 Drug use 104,141 Data from the US Burden of Disease Collaborators, 2021. CHAPTER 14 CMDT 2023 Table 1–3. Advisory Committee on Immunization Practices vaccine recommendations, 2021. Vaccine Recommendation Comment Influenza Routine vaccination for all persons aged 6 months and older, including all adults An alternative high-dose inactivated vaccine is available for adults aged 65 years and older When vaccine supply is limited, certain groups should be given priority, such as adults aged 50 years and older, individuals with chronic illness or immunosuppression, and pregnant women

Meer zien Lees minder
Instelling
Vak

Voorbeeld van de inhoud

, a LANGE medical book



2023
CURRENT
Medical Diagnosis
& Treatment
SIXT Y-SECOND EDITION

Edited by
Maxine A. Papadakis, MD
Professor of Medicine, Emeritus
Department of Medicine
University of California, San Francisco

Stephen J. McPhee, MD
Professor of Medicine, Emeritus
Division of General Internal Medicine
Department of Medicine
University of California, San Francisco

Michael W. Rabow, MD
Professor of Medicine and Urology
Division of Palliative Medicine
Department of Medicine
University of California, San Francisco

Associate Editor

Kenneth R. McQuaid, MD
Professor of Medicine
Department of Medicine
University of California, San Francisco

With Contributing Authors




New York Chicago San Francisco Athens London Madrid Mexico City
Milan New Delhi Singapore Sydney Toronto




CMDT2023_FM_pi-xx.indd 1 30/06/22 2:57 PM

,Copyright © 2023 by McGraw Hill. All rights reserved. Except as permitted under the United States Copyright Act of 1976,
no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval
system, without the prior written permission of the publisher.

ISBN: 978-1-26-468774-9
MHID: 1-26-468774-5

The material in this eBook also appears in the print version of this title: ISBN: 978-1-26-468734-3,
MHID: 1-26-468734-6.

eBook conversion by codeMantra
Version 1.0

All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after every occurrence of a
trademarked name, we use names in an editorial fashion only, and to the benet of the trademark owner, with no intention of
infringement of the trademark. Where such designations appear in this book, they have been printed with initial caps.

McGraw Hill eBooks are available at special quantity discounts to use as premiums and sales promotions, or for use in corpo-
rate training programs. To contact a representative, please visit the Contact Us pages at www.mhprofessional.com.

Notice

Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment
and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in
their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publica-
tion. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher
nor any other party who has been involved in the preparation or publication of this work warrants that the information con-
tained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for
the results obtained from use of the information contained in this work. Readers are encouraged to conrm the information
contained herein with other sources. For example and in particular, readers are advised to check the product information sheet
included in the package of each medication they plan to administer to be certain that the information contained in this work is
accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This
recommendation is of particular importance in connection with new or infrequently used medications.

TERMS OF USE

This is a copyrighted work and McGraw-Hill Education and its licensors reserve all rights in and to the work. Use of this work
is subject to these terms. Except as permitted under the Copyright Act of 1976 and the right to store and retrieve one copy
of the work, you may not decompile, disassemble, reverse engineer, reproduce, modify, create derivative works based upon,
transmit, distribute, disseminate, sell, publish or sublicense the work or any part of it without McGraw-Hill Education’s prior
consent. You may use the work for your own noncommercial and personal use; any other use of the work is strictly prohibited.
Your right to use the work may be terminated if you fail to comply with these terms.

THE WORK IS PROVIDED “AS IS.” McGRAW-HILL EDUCATION AND ITS LICENSORS MAKE NO GUARAN-
TEES OR WARRANTIES AS TO THE ACCURACY, ADEQUACY OR COMPLETENESS OF OR RESULTS TO BE
OBTAINED FROM USING THE WORK, INCLUDING ANY INFORMATION THAT CAN BE ACCESSED THROUGH
THE WORK VIA HYPERLINK OR OTHERWISE, AND EXPRESSLY DISCLAIM ANY WARRANTY, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS
FOR A PARTICULAR PURPOSE. McGraw-Hill Education and its licensors do not warrant or guarantee that the functions
contained in the work will meet your requirements or that its operation will be uninterrupted or error free. Neither McGraw-
Hill Education nor its licensors shall be liable to you or anyone else for any inaccuracy, error or omission, regardless of cause,
in the work or for any damages resulting therefrom. McGraw-Hill Education has no responsibility for the content of any
information accessed through the work. Under no circumstances shall McGraw-Hill Education and/or its licensors be liable
for any indirect, incidental, special, punitive, consequential or similar damages that result from the use of or inability to use
the work, even if any of them has been advised of the possibility of such damages. This limitation of liability shall apply to
any claim or cause whatsoever whether such claim or cause arises in contract, tort or otherwise.

, Contents
Authors v 13. Blood Disorders 500
Preface xiii
Dedication xvii Lloyd E. Damon, MD, &
Charalambos Babis Andreadis, MD, MSCE
Year in Review: Key Clinical Updates in
CMDT 2023 14. Disorders of Hemostasis, Thrombosis,
& Antithrombotic Therapy 546
1. Disease Prevention & Health Promotion 1
Andrew D. Leavitt, MD, &
Michael Pignone, MD, MPH, & René Salazar, MD Erika Leemann Price, MD, MPH
2. Common Symptoms 15
15. Gastrointestinal Disorders 579
Paul L. Nadler, MD, & Ralph Gonzales, MD, MSPH
Kenneth R. McQuaid, MD
3. Preoperative Evaluation &
Perioperative Management 42 16. Liver, Biliary Tract, & Pancreas
Hugo Q. Cheng, MD
Disorders 674
Lawrence S. Friedman, MD
4. Geriatric Disorders 52
Leah J. Witt, MD, Rossana Lau-Ng, MD, & 17. Breast Disorders 737
G. Michael Harper, MD Armando E. Giuliano, MD, FACS, FRCSEd, &
Sara A. Hurvitz, MD, FACP
5. Palliative Care & Pain Management 69
Michael W. Rabow, MD, Steven Z. Pantilat, MD, 18. Gynecologic Disorders 763
Ann Cai Shah, MD, Lawrence Poree, MD, MPH, PhD,
& Raj Mitra, MD Jill Brown, MD, MPH, MHS, FACOG, &
Katerina Shvartsman, MD, FACOG
6. Dermatologic Disorders 101
19. Obstetrics & Obstetric Disorders 794
Kanade Shinkai, MD, PhD, & Lindy P. Fox, MD
Vanessa L. Rogers, MD, & Scott W. Roberts, MD
7. Disorders of the Eyes & Lids 168
Jacque L. Duncan, MD, Neeti B. Parikh, MD, & 20. Rheumatologic, Immunologic,
Gerami D. Seitzman, MD & Allergic Disorders 819
Rebecca L. Manno, MD, MHS, Jinoos Yazdany, MD,
8. Otolaryngology Disorders 204 MPH, Teresa K. Tarrant, MD, & Mildred Kwan, MD, PhD
Elliott D. Kozin, MD, & Lawrence R. Lustig, MD
21. Electrolyte & AcidBase Disorders 875
9. Pulmonary Disorders 244
Nayan Arora, MD, & J. Ashley Jefferson, MD, FRCP
Meghan E. Fitzpatrick, MD, Niall T. Prendergast,
MD, & Belinda Rivera-Lebron, MD, MS, FCCP 22. Kidney Disease 903
10. Heart Disease 323 Tonja C. Dirkx, MD, & Tyler B. Woodell, MD, MCR
Todd Kiefer, MD, Christopher B. Granger, MD, &
Kevin P. Jackson, MD 23. Urologic Disorders 943
Mathew Sorensen, MD, MS, FACS,
11. Systemic Hypertension 442 Thomas J. Walsh, MD, MS, & Brian J. Jordan, MD
Michael Sutters, MD, MRCP (UK)
24. Nervous System Disorders 970
12. Blood Vessel & Lymphatic Disorders 473
Vanja C. Douglas, MD, &
Warren J. Gasper, MD, James C. Iannuzzi, MD, MPH, Michael J. Aminoff, MD, DSc, FRCP
& Meshell D. Johnson, MD

iii


CMDT2023_FM_pi-xx.indd 3 30/06/22 2:57 PM

Geschreven voor

Vak

Documentinformatie

Geüpload op
14 juni 2023
Aantal pagina's
849
Geschreven in
2022/2023
Type
SAMENVATTING

Onderwerpen

$12.49
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF

Maak kennis met de verkoper

Seller avatar
De reputatie van een verkoper is gebaseerd op het aantal documenten dat iemand tegen betaling verkocht heeft en de beoordelingen die voor die items ontvangen zijn. Er zijn drie niveau’s te onderscheiden: brons, zilver en goud. Hoe beter de reputatie, hoe meer de kwaliteit van zijn of haar werk te vertrouwen is.
LearnWithLeo Havard college
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
2603
Lid sinds
2 jaar
Aantal volgers
13
Documenten
6203
Laatst verkocht
2 dagen geleden

4.8

218 beoordelingen

5
195
4
15
3
5
2
2
1
1

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen